Article info
Congenital heart disease
Original research
Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease
- Correspondence to Dr Teresa Segura de la Cal, Adult Congenital Heart Disease Unit, Department of Cardiology, Hospital Universitario 12 de Octubre, Madrid, 28041, Spain; teresaseguradelacal{at}gmail.com
Citation
Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease
Publication history
- Received May 25, 2023
- Accepted October 3, 2023
- First published October 30, 2023.
Online issue publication
February 12, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.